DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY

This adverse event was reported 947 times

These drugs are most commonly taken by patients reporting DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY:

# Drug Count
0 RITUXIMAB 468
1 CYCLOPHOSPHAMIDE 408
2 CYCLOPHOSPHAMIDE FOR INJECTION 408
3 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 408
4 DOXORUBICIN 364
5 ETOPOSIDE 292
6 PREDNISONE 280
7 DEXAMETHASONE 250
8 DEXAMETHASONE 1.5 MG 250
9 CYTARABINE 235
See all common drugs associated with DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY

DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 EPCORITAMAB-BYSP 235 0.1756
1 HEXYLRESORCINOL 1 0.0455
2 CASPOFUNGIN ACETATE 48 0.0303
3 RITUXIMAB AND HYALURONIDASE 12 0.0265
4 LONCASTUXIMAB TESIRINE 6 0.0146
5 POLATUZUMAB VEDOTIN 114 0.0112
6 IFOSFAMIDE FOR INJECTION 163 0.0076
7 GLOFITAMAB 17 0.0063
8 ALBUMIN HUMAN 29 0.0058
9 SELINEXOR 51 0.0058
See all drugs enriched for association with DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY